Cardio Diagnostics (CDIO) Projected to Post Quarterly Earnings on Monday

Cardio Diagnostics (NASDAQ:CDIO) is projected to post its quarterly earnings results before the market opens on Monday, April 7th. Analysts expect Cardio Diagnostics to post earnings of ($0.16) per share and revenue of $0.03 million for the quarter.

Cardio Diagnostics Price Performance

Shares of NASDAQ:CDIO opened at $0.38 on Monday. Cardio Diagnostics has a 52-week low of $0.19 and a 52-week high of $1.77. The stock has a 50 day moving average price of $0.48 and a 200-day moving average price of $0.48.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.